The control of medical doctors in Belgium

Rita Schepers1, Herman Nys, Panayota Mokos

  • 1Medical Sociology, Catholic University of Louvain, Belgium.

Medicine and Law
|November 10, 2004
PubMed

Insights

This study examines Belgium's medical regulatory bodies, including the Order of Physicians, provincial medical committees, and the medical control service, identifying key obstacles to effective physician self-regulation and control.

Area of Science:

  • Medical Regulation
  • Public Health Policy
  • Healthcare Administration

Background:

  • The Belgian healthcare system relies on specific institutions for medical oversight.
  • Understanding the structure and function of these bodies is crucial for effective medical governance.

Purpose of the Study:

  • To present the structure and purpose of three Belgian medical control institutions.
  • To discuss the operational data of these regulatory bodies.
  • To identify obstacles hindering efficient medical self-regulation and control.

Main Methods:

  • Descriptive analysis of institutional structures and purposes.
  • Discussion of operational data from regulatory bodies.
  • Qualitative research findings on obstacles to self-regulation.

Main Results:

  • Detailed overview of the Order of Physicians, provincial medical committees, and the medical control service.
  • Insights into the practical functioning and performance of these institutions.
  • Identification of specific challenges impacting medical doctors' self-regulation.

Conclusions:

  • The current self-regulation and control mechanisms for medical doctors in Belgium face significant obstacles.
  • Addressing these identified obstacles is essential for enhancing the effectiveness and efficiency of medical governance.

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Methods for Controlling Microbial Growth01:29

Methods for Controlling Microbial Growth

Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...